AlemtuzumabHyperthyroidism and hypothyroidism: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1791卷 / 1期

关键词：

D O I：

10.1007/s40278-020-74866-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：21 / 21

相关论文

共 50 条

[1] AlemtuzumabHyperthyroidism and hypothyroidism: 4 case reports
Reactions Weekly, 2020, 1791 (1) : 22 - 22
[2] AlemtuzumabHyperthyroidism/thyrotoxicosis: 4 case reports
Reactions Weekly, 2017, 1676 (1) : 18 - 18
[3] OxcarbazepineCentral hypothyroidism: 3 case reports
Reactions Weekly, 2020, 1830 (1) : 261 - 261
[4] NivolumabThyrotoxicosis and hypothyroidism: 3 case reports
Reactions Weekly, 2018, 1724 (1) : 277 - 277
[5] Atezolizumab/nivolumabOvert hypothyroidism and subclinical hypothyroidism: 3 case reports
Reactions Weekly, 2022, 1934 (1) : 89 - 89
[6] AlemtuzumabHyperthyroidism, fluctuating Graves' disease and hypothyroid: 21 case reports
Reactions Weekly, 2019, 1741 (1) : 19 - 19
[7] OxcarbazepineFirst report of hypothyroidism: 3 case reports
Reactions Weekly, 2006, 1101 (1) : 15 - 15
[8] PembrolizumabColitis, hypothyroidism and pneumonitis: 3 case reports
Reactions Weekly, 2023, 1945 (1) : 436 - 436
[9] NivolumabLichen planus and hypothyroidism: 3 case reports
Reactions Weekly, 2018, 1711 (1) : 223 - 223
[10] SunitinibThyroid dysfunction and hypothyroidism: 3 case reports
Reactions Weekly, 2019, 1770 (1) : 358 - 358

← 1 2 3 4 5 →